125 filings
Page 2 of 7
8-K
g2vpwb615x65rcw81d
12 May 22
Salarius Pharmaceuticals Reports Business Highlights with First Quarter 2022 Financial Results
4:14pm
8-K
5r7587n
26 Apr 22
Other Events
5:14pm
8-K
9ncf29q
22 Apr 22
Salarius Pharmaceuticals, Inc. Announces $2.3 Million Registered Direct Offering
8:47am
8-K
5xv48xb
1 Apr 22
Amendments to Articles of Incorporation or Bylaws
4:01pm
8-K
gbipt
10 Mar 22
Salarius Pharmaceuticals Reports Business Highlights with Fourth Quarter and Full-Year 2021 Financial Results
4:12pm
8-K
5ui2cgikhuq jl3ij
13 Jan 22
Salarius Pharmaceuticals Expands Oncology Pipeline Through Strategic Acquisition of Targeted Protein Degradation Portfolio from DeuteRx, LLC
4:05pm
8-K
czvsew3m9uem
19 Nov 21
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
5:17pm
8-K
m795ykwk3gvaye3
16 Sep 21
Other Events
4:26pm
8-K
mhyjcykd dnhqffttt44
20 Aug 21
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
5:00pm
8-K
vo8or
5 Aug 21
Salarius Pharmaceuticals Reports Second Quarter 2021 Financial Results and Highlights Recent Company Progress
4:13pm
8-K
e2d92gzf
2 Jul 21
Other Events
5:07pm
8-K
lwrl0x5ij78yeq07el
1 Jul 21
Other Events
5:18pm
8-K
3udugi
16 Jun 21
Submission of Matters to a Vote of Security Holders
4:27pm
8-K
5jcvaw95
20 May 21
Other Events
7:57am
8-K
6wwqofq 6j0kyz7qo
12 May 21
Salarius Pharmaceuticals Reports First Quarter Financial Results with Business Highlights
4:03pm
8-K
azjqkupi
8 Mar 21
Salarius Announces Pricing of $20 Million Underwritten Public Offering of Common Stock
4:30pm
8-K
3ka 1pjj3
3 Mar 21
Salarius Announces Proposed Public Offering of Common Stock
4:23pm
8-K
fqe6inure4swnj1pkk
17 Feb 21
Other Events
4:00pm
8-K
s63bnee
5 Feb 21
Entry into a Material Definitive Agreement
4:41pm
8-K
dzci7
21 Jan 21
Other Events
8:00am